13F Data
13F filer · CIK 1715579

Medicxi Ventures Management (Jersey) Ltd

ST. HELIER, Y9 · filing since Q4 2019 · last filing Nov 2, 2026
Reported value
$126.7M
$-50.8M vs prior
Positions
3
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $639.6K
Top-10 weight
100.0%

Biggest buys vs Q2 2026

No new or increased positions this quarter.

Biggest sells vs Q2 2026

ChangeSecurityShares changeChange %Est. trade value
ReducedNEWAMSTERDAM PHARMA COMPANY-26,300-1.2%$-639.6K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2019: $163.2MQ1 2020: $76.5MQ2 2020: $162.7MQ3 2020: $209.4MQ4 2020: $172.1MQ1 2021: $171.7MQ2 2021: $558.0MQ3 2021: $459.6MQ4 2021: $399.6MQ1 2022: $369.1MQ2 2022: $240.8MQ3 2022: $240.2MQ4 2022: $238.1MQ1 2023: $233.4MQ2 2023: $356.9MQ3 2023: $313.2MQ4 2023: $296.2MQ1 2024: $449.2MQ2 2024: $335.3MQ3 2024: $528.9MQ4 2024: $529.0MQ1 2025: $437.7MQ2 2025: $427.3MQ3 2025: $744.4MQ4 2025: $835.0MQ1 2026: $981.8MQ2 2026: $177.4MQ3 2026: $126.7M
Q4 2019Q3 2026

Holdings · Q3 2026

#SecuritySharesValueWeight
1PHATHOM PHARMACEUTICALS INCCOM7,464,572$54.5M43.02%
2NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES2,182,339$53.1M41.90%
3AURA BIOSCIENCES INCCOM3,039,892$19.1M15.07%